All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is an independent medical education platform. This activity is supported by an educational grant from Lilly. Funders are allowed no direct influence on our content.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View psoriasis and psoriatic arthritis content recommended for you
Results from a cross-sectional study investigating the association between depressive symptoms and psoriasis (PsO) in 15,863 patients using data from the National Health and Nutrition Examination Survey (NHANES; 2009–2014) were published in Medicine by Wen et al. The aim of this study was to evaluate sex differences in the relationship between depression and PsO. Three regression models were constructed: Model 1, in which no adjustments were applied; Model 2, in which age, gender, race, body mass index (BMI), income-to-poverty ratio (PIR), and education level were considered; and Model 3, in which age, gender, race, BMI, PIR, education level, drinking behavior, and smoking habits were considered.
Key data: A robust association between higher Patient Health Questionnaire-9 (PHQ-9) scores and PsO was identified in Model 1 (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.02–1.06; p < 0.001), Model 2 (OR, 1.05; 95% CI, 1.02–1.07; p = 0.001), and Model 3 (OR, 1.04; 95% CI, 1.01–1.07; p = 0.01) vs patients without depression. In subsequent analyses, using a PHQ-9 threshold score ≥5, an association between depression and PsO was confirmed with Model 1 (p = 0.004), Model 2 (p = 0.01), and Model 3 (p = 0.01). Males with depression exhibited an elevated likelihood of PsO onset (p < 0.001), with the OR of PsO increasing with higher PHQ9 scores (p < 0.001), whereas no statistically significant association was observed in females.
Key learning: Higher PHQ-9 scores were positively associated with PsO prevalence, with a sex-specific effect observed exclusively in males, highlighting the importance of monitoring PsO occurrence and implementing early screening in men with depression.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content